Bridget L. Leonard
University of Auckland
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bridget L. Leonard.
Diabetes | 2004
Garth J. S. Cooper; Anthony R. J. Phillips; Soon Y. Choong; Bridget L. Leonard; David J. Crossman; Dianne H. Brunton; Etuate L. Saafi; Ajith M. Dissanayake; Brett R. Cowan; Alistair A. Young; Christopher J. Occleshaw; Yih-Kai Chan; Fiona E. Leahy; Geraldine F. Keogh; G. Gamble; Grant R. Allen; Adèle J. Pope; Peter D. W. Boyd; Sally D. Poppitt; Thomas K. Borg; Robert N. Doughty; John Richard Baker
Heart disease is the major cause of death in diabetes, a disorder characterized by chronic hyperglycemia and cardiovascular complications. Although altered systemic regulation of transition metals in diabetes has been the subject of previous investigation, it is not known whether changed transition metal metabolism results in heart disease in common forms of diabetes and whether metal chelation can reverse the condition. We found that administration of the Cu-selective transition metal chelator trientine to rats with streptozotocin-induced diabetes caused increased urinary Cu excretion compared with matched controls. A Cu(II)-trientine complex was demonstrated in the urine of treated rats. In diabetic animals with established heart failure, we show here for the first time that 7 weeks of oral trientine therapy significantly alleviated heart failure without lowering blood glucose, substantially improved cardiomyocyte structure, and reversed elevations in left ventricular collagen and beta(1) integrin. Oral trientine treatment also caused elevated Cu excretion in humans with type 2 diabetes, in whom 6 months of treatment caused elevated left ventricular mass to decline significantly toward normal. These data implicate accumulation of elevated loosely bound Cu in the mechanism of cardiac damage in diabetes and support the use of selective Cu chelation in the treatment of this condition.
Clinical and Experimental Pharmacology and Physiology | 2000
Simon C. Malpas; Bridget L. Leonard
1. The importance of renal sympathetic nerve activity (RSNA) in the regulation of renal function is well established. However, it is less clear how the renal vasculature responds to the different mean levels and patterns of RSNA. While many studies have indicated that small to moderate changes in RSNA preferentially regulate renin secretion or sodium excretion and only large changes in RSNA regulate renal blood flow (RBF), other experimental evidence suggests that small changes in RSNA can influence RBF
Autonomic Neuroscience: Basic and Clinical | 2000
Bridget L. Leonard; Michael A. Navakatikyan; Simon C. Malpas
Renal sympathetic nerve activity (RSNA) and renal blood flow (RBF) both show oscillations at various frequencies but the functional significance and regulation of these oscillations is not well understood. To establish whether the strength of these oscillations is under differential control we measured the frequency spectrum of RSNA and RBF following volume expansion in conscious rabbits. Seven days prior to experiment animals underwent surgery to implant an electrode for recording renal nerve activity and a flow probe for recording RBF. Volume expansion (Haemaccel, 1.5 ml min(-1) kg(-1) for 15 min) resulted in a 25 +/- 5% decrease in mean RSNA, paralleled by an increase in RBF to 60 +/- 12 ml min(-1) from resting levels of 51 +/- 11 ml min(-1). Renal denervated rabbits did not show an increase in RBF with volume expansion. Arterial baroreflexes were unaltered by volume expansion. Spectral analysis of the different frequencies in RSNA showed oscillations in RSNA between 0.2 and 0.4 Hz were selectively decreased following volume expansion (14 +/- 3 to 6 +/- 1% of total power in RSNA at < 3 Hz). A corresponding decrease in the strength of oscillations in RBF at this frequency was also seen (20 +/- 6 to 8 +/- 2%). In contrast, the strength of respiratory (0.8-2.0 Hz) and cardiac (3-6 Hz) related rhythms did not change with volume expansion. These results show that selective changes in the different frequency components of RSNA can occur. We suggest that input from cardiopulmonary receptors and/or other vascular beds, and/or altered vascular resistance after volume expansion can reduce the strength of the 0.3 Hz oscillation independent of changes in arterial baroreflex control of RSNA.
IEEE Engineering in Medicine and Biology Magazine | 2001
Simon C. Malpas; Bridget L. Leonard; Sarah-Jane Guild; John Ringwood; Michael A. Navakatikyan; Paul C. Austin; Geoffrey A. Head; Don E. Burgess
This article focuses on how sympathetic nerve activity (SNA) contributes to the variability seen in blood pressure. Specifically, it examines the following questions: why do oscillations occur at certain frequencies, why do only certain frequencies of oscillations in SNA induce oscillations in the vasculature, and what may be the functional purpose of these oscillations.
Acta Diabetologica | 2005
Bridget L. Leonard; R. N. Watson; Kerry M. Loomes; Anthony R. J. Phillips; Garth J. S. Cooper
American Journal of Physiology-regulatory Integrative and Comparative Physiology | 2000
Bridget L. Leonard; Roger G. Evans; Michael A. Navakatikyan; Simon C. Malpas
American Journal of Physiology-regulatory Integrative and Comparative Physiology | 2001
Bridget L. Leonard; Simon C. Malpas; Kate M. Denton; Anna C. Madden; Roger G. Evans
American Journal of Physiology-regulatory Integrative and Comparative Physiology | 2002
Huang-Ku Liu; Sarah-Jane Guild; John Ringwood; Carolyn J. Barrett; Bridget L. Leonard; Sing-Kiong Nguang; Michael A. Navakatikyan; Simon C. Malpas
Microscopy and Microanalysis | 2012
Bridget L. Leonard; Bruce H. Smaill; Ian J. LeGrice
Endocrinology | 2008
Rachel N. Danaher; Kerry M. Loomes; Bridget L. Leonard; Lynda Whiting; Debbie L. Hay; Lance Yi Xu; Edward W. Kraegen; Anthony R. J. Phillips; Garth J. S. Cooper